Cargando…
Imatinib might constitute a treatment option for lung involvement in COVID-19
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252139/ https://www.ncbi.nlm.nih.gov/pubmed/32376403 http://dx.doi.org/10.1016/j.autrev.2020.102565 |
| _version_ | 1783539099289780224 |
|---|---|
| author | Bernal-Bello, David Jaenes-Barrios, Beatriz Morales-Ortega, Alejandro Ruiz-Giardin, José Manuel García-Bermúdez, Virginia Frutos-Pérez, Begoña Farfán-Sedano, Ana Isabel de Ancos-Aracil, Cristina Bermejo, Fernando García-Gil, Mario Zapatero-Gaviria, Antonio San Martín-López, Juan Víctor |
| author_facet | Bernal-Bello, David Jaenes-Barrios, Beatriz Morales-Ortega, Alejandro Ruiz-Giardin, José Manuel García-Bermúdez, Virginia Frutos-Pérez, Begoña Farfán-Sedano, Ana Isabel de Ancos-Aracil, Cristina Bermejo, Fernando García-Gil, Mario Zapatero-Gaviria, Antonio San Martín-López, Juan Víctor |
| author_sort | Bernal-Bello, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7252139 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72521392020-05-28 Imatinib might constitute a treatment option for lung involvement in COVID-19 Bernal-Bello, David Jaenes-Barrios, Beatriz Morales-Ortega, Alejandro Ruiz-Giardin, José Manuel García-Bermúdez, Virginia Frutos-Pérez, Begoña Farfán-Sedano, Ana Isabel de Ancos-Aracil, Cristina Bermejo, Fernando García-Gil, Mario Zapatero-Gaviria, Antonio San Martín-López, Juan Víctor Autoimmun Rev Article Elsevier B.V. 2020-07 2020-05-03 /pmc/articles/PMC7252139/ /pubmed/32376403 http://dx.doi.org/10.1016/j.autrev.2020.102565 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Bernal-Bello, David Jaenes-Barrios, Beatriz Morales-Ortega, Alejandro Ruiz-Giardin, José Manuel García-Bermúdez, Virginia Frutos-Pérez, Begoña Farfán-Sedano, Ana Isabel de Ancos-Aracil, Cristina Bermejo, Fernando García-Gil, Mario Zapatero-Gaviria, Antonio San Martín-López, Juan Víctor Imatinib might constitute a treatment option for lung involvement in COVID-19 |
| title | Imatinib might constitute a treatment option for lung involvement in COVID-19 |
| title_full | Imatinib might constitute a treatment option for lung involvement in COVID-19 |
| title_fullStr | Imatinib might constitute a treatment option for lung involvement in COVID-19 |
| title_full_unstemmed | Imatinib might constitute a treatment option for lung involvement in COVID-19 |
| title_short | Imatinib might constitute a treatment option for lung involvement in COVID-19 |
| title_sort | imatinib might constitute a treatment option for lung involvement in covid-19 |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252139/ https://www.ncbi.nlm.nih.gov/pubmed/32376403 http://dx.doi.org/10.1016/j.autrev.2020.102565 |
| work_keys_str_mv | AT bernalbellodavid imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT jaenesbarriosbeatriz imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT moralesortegaalejandro imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT ruizgiardinjosemanuel imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT garciabermudezvirginia imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT frutosperezbegona imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT farfansedanoanaisabel imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT deancosaracilcristina imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT bermejofernando imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT garciagilmario imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT zapaterogaviriaantonio imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 AT sanmartinlopezjuanvictor imatinibmightconstituteatreatmentoptionforlunginvolvementincovid19 |